Pacific Center for Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.3K | Sell |
612
-5
| -0.8% | -$659 | 0.02% | 177 |
|
|
2026
Q1 | $86K | Buy |
617
+13
| +2% | +$1.82K | 0.02% | 157 |
|
|
2025
Q4 | $67.1K | Hold |
604
| – | – | 0.02% | 177 |
|
|
2025
Q3 | $67.1K | Buy |
604
+3
| +0.5% | +$341 | 0.02% | 177 |
|
|
2025
Q2 | $66.7K | Buy |
601
+2
| +0.3% | +$213 | 0.02% | 168 |
|
|
2025
Q1 | $67.1K | Buy |
599
+3
| +0.5% | +$310 | 0.02% | 165 |
|
|
2024
Q4 | $55K | Buy |
596
+3
| +0.5% | +$270 | 0.01% | 180 |
|
|
2024
Q3 | $49.7K | Buy |
593
+4
| +0.7% | +$305 | 0.01% | 186 |
|
|
2024
Q2 | $40.4K | Buy |
589
+4
| +0.7% | +$267 | 0.01% | 193 |
|
|
2024
Q1 | $42.8K | Buy |
585
+4
| +0.7% | +$308 | 0.01% | 195 |
|
|
2023
Q4 | $47.1K | Buy |
581
+3
| +0.5% | +$233 | 0.01% | 176 |
|
|
2023
Q3 | $43.3K | Buy |
578
+4
| +0.7% | +$308 | 0.01% | 181 |
|
|
2023
Q2 | $44.2K | Buy |
574
+3
| +0.5% | +$239 | 0.01% | 174 |
|
|
2023
Q1 | $47.3K | Buy |
+571
| New | +$47.3K | 0.02% | 169 |
|
|
2022
Q3 | $35K | Buy |
564
+4
| +0.7% | +$252 | 0.01% | 186 |
|
|
2022
Q2 | $35K | Buy |
560
+4
| +0.7% | +$248 | 0.01% | 183 |
|
|
2022
Q1 | $33K | Buy |
556
+4
| +0.7% | +$256 | 0.01% | 185 |
|
|
2021
Q4 | $40K | Buy |
552
+3
| +0.5% | +$207 | 0.02% | 178 |
|
|
2021
Q3 | $38K | Buy |
549
+4
| +0.7% | +$281 | 0.02% | 179 |
|
|
2021
Q2 | $38K | Buy |
545
+3
| +0.6% | +$200 | 0.02% | 175 |
|
|
2021
Q1 | $35K | Buy |
542
+4
| +0.7% | +$258 | 0.02% | 171 |
|
|
2020
Q4 | $31K | Buy |
538
+51
| +10% | +$3.08K | 0.01% | 177 |
|
|
2020
Q3 | $31K | Buy |
487
+3
| +0.6% | +$208 | 0.01% | 148 |
|
|
2020
Q2 | $37K | Buy |
484
+274
| +130% | +$21K | 0.02% | 128 |
|
|
2020
Q1 | $16K | Hold |
210
| – | – | 0.01% | 166 |
|
|
2019
Q4 | $14K | Hold |
210
| – | – | 0.01% | 190 |
|
|
2019
Q3 | $13K | Hold |
210
| – | – | 0.01% | 198 |
|
|
2019
Q2 | $14K | Sell |
210
-21
| -9% | -$1.38K | 0.01% | 192 |
|
|
2019
Q1 | $15K | Hold |
231
| – | – | 0.01% | 183 |
|
|
2018
Q4 | $14K | Hold |
231
| – | – | 0.01% | 190 |
|
|
2018
Q3 | $18K | Hold |
231
| – | – | 0.01% | 173 |
|
|
2018
Q2 | $16K | Hold |
231
| – | – | 0.01% | 171 |
|
|
2018
Q1 | $17K | Hold |
231
| – | – | 0.01% | 165 |
|
|
2017
Q4 | $17K | Hold |
231
| – | – | 0.01% | 162 |
|
|
2017
Q3 | $19K | Hold |
231
| – | – | 0.01% | 153 |
|
|
2017
Q2 | $16K | Hold |
231
| – | – | 0.01% | 160 |
|
|
2017
Q1 | $16K | Hold |
231
| – | – | 0.01% | 154 |
|
|
2016
Q4 | $17K | Buy |
+231
| New | +$17.2K | 0.01% | 155 |
|
Other funds holding GILD
Pacific Center for Financial Services's GILD Position: Q2 2026 in Review
Pacific Center for Financial Services reduced its Gilead Sciences (GILD) stake by 0.81% in Q2 2026, selling an estimated $659 and leaving 612 shares worth $77.3K. The position accounts for 0.02% of the portfolio, ranked #177.
Pacific Center for Financial Services first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $86K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pacific Center for Financial Services held 612 shares of Gilead Sciences worth $77.3K as of Q2 2026.
- Pacific Center for Financial Services sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
- Gilead Sciences made up 0.02% of Pacific Center for Financial Services's portfolio in Q2 2026, its #177 holding.
- Pacific Center for Financial Services first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- Pacific Center for Financial Services's Gilead Sciences position peaked at $86K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.